Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

Co-pay Programs in the Crosshairs: An Evidence-based Response to Critics

Click here to register

Date:
Wednesday, December 4
Time: 11:00 a.m. PT/ 2:00 p.m. ET

We've heard the continuous drumbeat from payers and PBMs: “Co-pay programs interfere with generic substitution!” “They subvert cost-sharing ‘strategies' that payers put in place!” “They increase health care costs!” That's what they say, but what's the real truth? This presentation uses payers' own data to uncover the surprising evidence supporting co-pay offset programs.

Featured Speakers:
Chris Dowd, Senior Vice President of Market and Product Development, PSKW

E.M. (Mick) Kolassa, MBA, PhD – Founding Partner, Medical Marketing Economics

Sponsored by:

You must be a registered member of MMM to post a comment.

Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.